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Cerebrospinal fluid (CSF) pressure and composition are generally thought to be homogeneous within
small limits throughout all CSF compartments. CSF sampled during lumbar puncture therefore should be
representative for all CSF compartments. On the basis of clinical findings, histology and biochemical markers,
we present for the first time strong evidence that the subarachnoid spaces (SAS) of the optic nerve (ON) can
become separated from other CSF compartments in certain ON disorders, thus leading to an ON sheath
compartment syndrome. This may result in an abnormal concentration gradient of CSF molecular markers
determined in locally sampled CSF compared with CSF taken during lumbar puncture.
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Introduction
Cerebrospinal fluid (CSF) is mainly produced by the choroid
plexus epithelium in the ventricles, from where it flows into
interconnecting chambers, namely, the cisterns and the sub-
arachnoid spaces (SAS), including the SAS of the optic nerves
(ONs) (Dichiro, 1964; Bito and Vavson, 1966; Milohart,
1972; Wood, 1982). Recent findings demonstrate that CSF
dysfunction might be caused by changes of molecular flux
and CSF flow rate (Reiber, 2001), which in turn could result
in accumulation of toxic components. For example, abnor-
mal flow rates are thought to be the main cause for the
pathological protein concentrations seen in neurological dis-
orders such as Alzheimer’s disease (Felgenhauer, 1980; Reiber
and Felgenhauer, 1987; Tumani et al., 1998; Reiber, 2001).
Furthermore, recent studies have allowed for description of
theoretical models of CSF flux that are well supported by
empirically measured protein concentrations in the CSF
(Reiber, 1994, 2001). The CSF contains a variety of proteins,
of which 85% are derived from the blood, for example, albu-
min, immunoglobulin (Ig) G, whereas approximately 15%
are synthesized primarily in the brain, for example, beta-trace
protein, tau protein, S100 B protein and neuron-specific
enolase (NSE) (Reiber, 2001). Beta-trace protein (molecular
mass 25 kDa) is the most abundant synthesized protein in the
CSF. On the basis of amino acid sequencing it has been
identified as prostaglandin D (PGD) synthase and therefore
has biological active properties (Hoffman et al., 1993).
In contrast to all other cranial nerves, the ON (a white
matter tract of the central nervous system) is covered by the
meninges and surrounded by CSF throughout its entire
length. A rise in intracranial pressure thus may cause impair-
ment of axoplasmic transport leading to papilloedema
(Hayreh, 1964). Because CSF is assumed to communicate
freely among the different CSF compartments, it has been
concluded that there also exists a homogeneous pressure and
homogeneous concentration of CSF components. However,
to date, no data on measurements of actual protein concen-
trations in the perioptic CSF space (a subarachnoid space)
have been reported. Certainly, the fact that most patients with
papilloedema have more or less symmetric swelling of the
optic discs supports the assumption of free communication
among the CSF compartments; however, cases of asymmetric
and even completely unilateral papilloedema have been
reported (Killer et al., 1999, 2003a, b; Killer and Flammer,
2001), and a satisfactory pathophysiological explanation for
these phenomena is lacking. As the pressure gradient of CSF is
directed from intracranial towards the SAS of the ON, it is
difficult to understand how CSF can recycle from there, as a
change of direction of fluid in order to return to the site of
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resorption at the arachnoid villi is unlikely because of the
volume gradient of CSF. A CSF outflow pathway from the
SAS of the ON is therefore of physiological relevance to
prevent fluid accumulation. The recent discovery of lympha-
tic vessels in the dura of the human ON—and their ability to
drain CSF as demonstrated with a marker substance—may
offer a CSF outflow route from the perioptic space (Killer
et al., 1999, 2003). The results of experimental studies in
animals describe CSF drainage into lymphatic vessels
(Boulton et al., 1998; Johnston, 2000, 2003; Zakharov et al.,
2003). In cats CSF outflow from cisternal infusion to the
distal portion of the ON has been demonstrated
(Lu¨demann et al., 2005). In addition, the anatomy and the
arrangement of trabecula and septae in the SAS of the ON
offer the possibility that a one-way valve mechanism explains
local CSF entrapment as well as reduced influx of CSF into the
SAS of the ON (Killer et al., 1999, 2003) (Fig. 1). Unilateral
and highly asymmetric dilation of the SAS of the ON can
partly be explained by reduced local drainage on the side of
the more pronounced papilloedema or by a bigger resistance
to influx of CSF on the side of the less marked papilloedema.
Owing to the small size of the SAS of the ON, local pressure
measurements are difficult and to date have been performed
only in cadavers (Liu and Kahn, 1993).
Material and methods
We performed ON sheath fenestration (ONSF) (Galbraith and
Sullivan, 1973) in six patients after ophthalmological and neurolo-
gical examination including lumbar puncture in five patients. In five
patients MRI imaging of the brain and orbit was performed.
One patient underwent high-resolution computed tomography.
In one patient ONSF was performed on both ON. All patients
were operated at the same institution (Kantonsspital Aarau) by
the same surgeon (H. E. Killer). Three had unilateral optic disc
swelling: one from anterior ischaemic optic neuropathy, one from
ON sheath meningioma and one idiopathic optic disc swelling
(presumed from a local vascular cause). The other three patients
had highly asymmetric papilloedema: one from pachymeningitis,
one from idiopathic intracranial hypertension and one following
a cerebral haemorrhage.
Marked dilation of the perioptic CSF spaces was present on MR
imaging in all three patients with papilloedema. These MRI findings
were first described by Brodsky et al. (1998). Less-marked dilation
was present in the three patients with unilateral optic disc swelling.
CSF was collected in all patients from the SAS of the ON after the
‘CSF gush’ following the incision of the dura and from the lumbar
SAS at the time of the lumbar puncture. The CSF from both com-
partments was examined for the content of albumin, IgG and beta-
trace protein. For the determination of serum and CSF albumin, IgG
and beta-trace proteins, nephelometric methods were employed
using polyclonal antibodies and a nephelometer (BNII) from
Dade Behring, Marburg, Germany.
Results
Beta-trace concentrations of CSF obtained from the SAS of
the ON was 79.84 6 27.14 mg/l, whereas the CSF : serum
ratio of albumin and IgG was 0.24 6 0.17 and 0.21 6 0.15,
respectively. Further, beta-trace concentrations and albumin
and IgG ratio in CSF obtained from a spinal tap were
17.53 6 3.06, and 0.02 6 0.02 and 0.01 6 0.01 mg/l,
respectively. Reference values for beta-trace protein are
15.3 mg/l (Link and Olsson, 1972; Rubenstein, 1998)
(Figs 2 and 3).
Discussion
This paper describes six cases with unilateral optic disc
swelling and asymmetric papilloedema with distension of
the perioptic nerve sheath on orbital MRI or CT scan.
The CSF findings strongly suggest that the ON can develop
into a separate CSF compartment under certain pathological
conditions. In addition, despite different aetiologies of optic
disc swelling, the CSF obtained from the SAS of the ON in all
of these cases demonstrated markedly different biomarker
concentrations compared with those in the CSF obtained
from the corresponding lumbar SAS. These findings are con-
sistent with the compartmentalization of the SAS of the ON.
In addition, they suggest that additional mechanical damage
(e.g. elevated local pressure) as well as biochemical injury
through an accumulation of biologically active molecules
may contribute to disease progression and tissue damage to
Fig. 1 Histological studies of the meninges of the human ON.
(Courtesy of P. Groscurth, Department of Anatomy, University of
Zu¨rich, Switzerland). (A) Scanning electron microscopy of the
retrobulbar portion of the SAS of the ON. Note the complex
network of trabeculae bridging the SAS. (B) Transmission electron
microscopy of arachnoid trabeculae. Note the thin layer of
meningoepithelial cells surrounding each trabeculum and the
cytoplasmic bridges connecting adjacent trabeculae. The
anatomical arrangement of trabeculae and cytoplasmatic bridges
allow for local CSF entrapment in the SAS causing an ON sheath
compartment syndrome. (C) Lymphatic capillary in the dura of
the human ON sheath. Marker particles are visible in the lumen of
the vessel (asterisk). (D) Arachnoid layer with pore for CSF
outflow into the dura. Note the macrophage entering the pore.
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blood vessels, axons and neurons (Link and Olsson, 1972;
Logdberg and Wester, 2000; Urade and Hayaishi, 2000;
Reiber, 2001; Fujitani et al., 2002; Taniike et al., 2002;
Ragolia et al., 2003; Zakharov et al., 2003).
Although elevated concentrations of IgG and albumin,
seen in patients with blood-brain barrier dysfunction,
might have been caused by the surgical procedure, the
increased concentration of CSF beta-trace protein in the
SAS of the ON can only be due to abnormal local synthesis
or pathological flow dynamics (reduced beta-trace clearing)
in the occluded compartment. Whether or not this markedly
increased concentration of beta-trace further aggravates
compartmentalization is not known at this time. Ours is
the first report to provide information concerning the
biochemical constituents of the CSF in the SAS of the ON
and the difference between the concentrations of these
constituents in the perioptic SAS versus the lumbar SAS.
Furthermore, the results provide strong evidence for
compartmentalization of the SAS of the ON, thus leading
under certain circumstances to the development of an
ON sheath compartment syndrome. Several studies have
demonstrated apoptosis-inducing properties of beta-trace
in neuronal tissues (Link and Olsson, 1972; Logdberg
and Wester, 2000; Urade and Hayaishi, 2000; Fujitani et al.,
2002; Taniike et al., 2002; Ragolia et al., 2003). Given the
biological potential of some molecules in the CSF, it could be
postulated that the accumulation of these biologically active
molecules (e.g. beta-trace) in blocked compartments of the
CSF space would cause significant, possibly devastating,
damage to the tissues in the vicinity of the affected area.
A relationship between an impaired CSF circulatory system,
impaired clearance of noxious substances in the CSF
and dementias of the aged has recently been proposed
(Rubenstein, 1998; Silverberg et al., 2003). Following this
line of thought, our findings may prove helpful to shed a
new light onto the pathophysiology of progressive anterior
and posterior ischaemic optic neuropathy or more common
ON disorders, such as chronic open-angle and normal-
tension glaucoma, which in many cases show progressive
visual field loss despite well-regulated intraocular pressure,
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Diagnosis  
  
ONSM PM PM IODS SPC AION PC 
ON Side 
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LP Pressure  [cm H2O]  24 50 50 none  34 20 43 
Beta-Trace LP  [mg/L]  18.60 18.10 18.10 none 11.80 21.00 17.60 
Beta-Trace ON [mg/L]  49.90 103.00 124.00 81.10 71.10 80.90 48.90 
Albumin Ratio LP  (CSF/Serum)  0.01 0.03 0.03 none  0.03 0.00 0.00 
Albumin Ratio ON  (CSF/Serum)  0.52 0.20 0.11 0.14 0.09 0.43 0.21 
IgG Ratio LP  (CSF/Serum)  0.00 0.01 0.01 none  0.02 0.00 0.00 
IgG Ratio ON  (CSF/Serum)  0.45 0.13 none  0.12 0.05 0.32 0.17 
Fig. 2 Table and graph of CSF data from six patients. Table: The CSF samples are taken from seven SAS of the left (l) or/and the
right (r) ON from three male (m) (mean age 44.0 6 19.3 years) and three female (f ) (mean age 37.0 6 16.0 years) patients after informed
consent. Clinical diagnosis: pseudotumour cerebri (PC) and secondary pseudotumour cerebri (SPC), anterior ischaemic optic neuropathy
(AION), pachymeningitis (PM), idiopathic optic disc swelling (IODS) and ON sheath meningioma (ONSM). Lumbar
puncture (LP) was performed in five patients and markers determined as described. Graph: Beta trace (A; light bars) in (mg/l) 6 SD,
CSF/serum ratio of albumin (B, dark bars), and of IgG (C, hatched bars) of mean 6 SD and logarithmic from six patients
obtained by spinal tap (LP) and puncture of the SAS of the ON.
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suggesting additional pathophysiological components
(Gliklich et al., 1989).
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Fig. 3 Fundus photography and MRI studies of a patient with
unilateral papilloedema (due to nerve sheath meningioma).
(A) Unremarkable optic disc on the right. (B) Unilateral optic disc
swelling due to left ON sheath meningioma. (C) Distended
perioptic nerve sheath on the left with accumulation of CSF
(white on T2-weighted magnetic resonance image, axial view).
These radiological features meet the criteria for papilloedema
as described previously by Brodsky and Vaphiades (1998).
(D) Coronal view of the left orbit. Note marked distension of
the SAS and accumulation of CSF.
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